Rituximab: A very efficient therapy in cold agglutinins and refractory autoimmune haematolytic anaemia associated with CD20-positive, low-grade non-Hodgkin's lymphoma.
F. Bauduer, Rituximab: A very efficient therapy in cold agglutinins and refractory autoimmune haematolytic anaemia associated with CD20-positive, low-grade non-Hodgkin's lymphoma., BR J HAEM, 112(4), 2001, pp. 1085-1086